| Literature DB >> 9295219 |
D A Cory-Slechta1, R Pazmino, C Bare.
Abstract
Microinjections of the irreversible dopamine antagonist EEDQ (N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline), into nucleus accumbens but not into dorsal striatum, markedly decreased response rates on a fixed interval schedule of reinforcement. These preferential effects in nucleus accumbens could be prevented by selectively activating either D1 or D2 receptors. These data demonstrate a critical role for mesolimbic dopamine systems in the mediation of fixed interval schedule-controlled operant behavior.Entities:
Mesh:
Substances:
Year: 1997 PMID: 9295219 DOI: 10.1016/s0006-8993(97)00591-x
Source DB: PubMed Journal: Brain Res ISSN: 0006-8993 Impact factor: 3.252